5G NR Protocol Conformance Test Platform Provides Best Test Coverage

985
Advertisement
  • Anritsu’s 5G NR mobile device selected by PTCRB (PCS Type Certification Review Board) Validation group
  • The conformance tests have been validated on multiple Sub-6 GHz  and millimeter wave (mmWave) frequency bands

Anritsu Corporation has announced that the PTCRB (PCS Type Certification Review Board) Validation group (PVG) has agreed the highest number of 5G New Radio (NR) Protocol Conformance tests on the 5G NR Mobile Device Test Platform ME7834NR at their PVG meeting held in May, and these were subsequently approved in the PTCRB meeting held in June.

Anritsu validations included tests for Non-Standalone (NSA) mode, Standalone (SA) mode and frequency bands covering Time Division Duplex (TDD), and Frequency Division Duplex (FDD). As a result, the Anritsu ME7834NR maintains its position as a leading Protocol Conformance Test Platform for providing the best test coverage to chipset suppliers, device manufacturers and test houses and accelerate the certification, and introduction of new 5G devices and services.

The conformance tests are defined by 3GPP in TS 38.523, and have been validated on multiple Sub-6 GHz Frequency Range 1 (FR1) and millimeter wave (mmWave) Frequency Range 2 (FR2) frequency bands.

The 5G NR Mobile Device Test PlatformME7834NR is registered with both the Global Certification Forum (GCF) and PCS Type Certification Review Board (PTCRB) as Test Platform (TP) 251.

About the test platform

The 5G NR Mobile Device Test Platform ME7834NR is for 3GPP-based Protocol Conformance Test (PCT) and Carrier Acceptance Testing (CAT) of mobile devices incorporating Multiple Radio Access Technologies (RAT). It supports 5G NR in both Standalone (SA) and Non-Standalone (NSA) mode in addition to LTE, LTE-Advanced (LTE-A), LTE-A Pro and W-CDMA. When combined with Anritsu’s new OTA RF Chamber MA8171A and RF converters, the ME7834NR can cover the Sub-6 GHz and millimeter wave (mmWave) 5G frequency bands.


Advertisement


SHARE YOUR THOUGHTS & COMMENTS

Please enter your comment!
Please enter your name here